Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01030003 · ClinicalTrials.gov registry record

Snoring in Pregnancy and Adverse Maternal and Fetal Outcomes

A clinical trial, sponsored by University of Michigan.

Completed
Registry status
1,685
Enrollment target

NCT01030003 is a clinical trial that has completed, run by University of Michigan. The registered enrollment target is 1,685 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01030003 has completed, sponsored by University of Michigan.

COMPLETED
Registry status
1,685 participants
Enrollment target

Study Summary

The purpose of the study is to determine the prevalence of sleep-disordered breathing in pregnant women during the third trimester of pregnancy and to investigate whether this is associated with high blood pressure in the mother and/or growth retardation in the baby.

Trial Details

FieldValue
Enrollment Target 1,685 participants
Start Date 2007-01
Est. Completion 2011-08

Sponsor

University of Michigan

1,327 total trials

What the Registry Record Tells You About NCT01030003

The ClinicalTrials.gov registry entry for NCT01030003 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,685 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01030003 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01030003 about?

NCT01030003 is a clinical study titled "Snoring in Pregnancy and Adverse Maternal and Fetal Outcomes". The purpose of the study is to determine the prevalence of sleep-disordered breathing in pregnant women during the third trimester of pregnancy and to investigate whether this is associated with high blood pressure in the mother and/or growth retardation in the baby.

What is the current status of trial NCT01030003?

This trial is currently completed. The enrollment target is 1,685 participants. The study started on 2007-01. Estimated completion is 2011-08.

Who is sponsoring clinical trial NCT01030003?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.